Publications by authors named "Jeries Kort"

Claim this Profile
E
Efficacy and Safety of Daratumumab, Pomalidomide and Dexamethasone Compared to Daratumumab, Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma: Multicenter Real-World Experience.
Anas Zayad, Gray Magee, Razan Mansour, Mark Chang, Nausheen Ahmed, Jeries Kort

Clin Lymphoma Myeloma Leuk· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melphalan 140 mg/m is Safe and Effective for Frail and Older Multiple Myeloma Patients With Comparable Rates of Minimal Residual Disease Negativity.
Jeries Kort, Nikolas Naleid, Frank Oley, James Ignatz-Hoover, Seunghee Margevicius

Clin Lymphoma Myeloma Leuk· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revolutions at the frontline of multiple myeloma treatment: lessons and challenges to finding a cure.
Jeries Kort, Andrea Rivera, Sindhuja Senigarapu, James J Driscoll

Front Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-dominant disease in late-and-early-onset lupus: A systematic review and meta-analysis.
Sarah Abi Doumeth, Jeries Kort, Omer Nuri Pamuk

Autoimmun Rev· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial.
Ehsan Malek, Jeries Kort, Leland Metheny, Pingfu Fu, Gen Li

Transplant Cell Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial.
Ehsan Malek, Jeries Kort, Leland Metheny, Pingfu Fu, Parameswaran Hari

Res Sq· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction.
Priyanka S Rana, David C Soler, Jeries Kort, James J Driscoll

Front Cell Dev Biol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Road testing new CAR design strategies in multiple myeloma.
Priyanka S Rana, Elena V Murphy, Jeries Kort, James J Driscoll

Front Immunol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Replacing Vindesine with Vincristine in R-ACVBP Regimen for the Treatment of Large B Cell Lymphomas.
Rola El Sayed, Haidar El Darsa, Jeries Kort, Farouk Al Chami, Ali Ibrahim

Clin Lymphoma Myeloma Leuk· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of four cycles of Brentuximab Vedotin as consolidation after autologous peripheral stem cell transplantation in relapsed/refractory Hodgkin lymphoma.
Jeries Kort, Amanda Chidiac, Rola El Sayed, Radwan Massoud, Rita Nehme

Leuk Lymphoma· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer: Insights to Sequencing Treatment and Overcoming Resistance Based on Clinical Trials.
Rola El Sayed, Lara El Jamal, Sarah El Iskandarani, Jeries Kort, Mahmoud Abdel Salam

Front Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis